簡介中醫藥瀏覽 TCM Profile
首頁 > 中醫藥瀏覽 > 活血化淤藥 > 活血調經藥 > 澤蘭
重新搜尋
| 藥材 | Compound | |
|
(-)-syringaresinol 2α,19α-Dihydroxyursolic acid 3-epioleanolic acid 3-Epiursolic Acid 3-o-(caffeoyl)-rosmarinic,acid 3-O-(caffeoyl)rosmarinic acid-9'methylester 3-o-[beta-d-xylopyranosyl-(1-6)-beta-d-glucopyranosyl]-(3r)-1-octen-3-ol acacetin-7-o-beta-d-glucuronopyranoside apigenin betulinic,acid clinopodic,acid,c clinopodic,acid,e hispidulin jionoside D luteolin-7-o-beta-d-glucuronide,methyl,ester lycopic,acid,a lycopic,acid,b lycopic,acid,c Lycopose methyl,rosmarinate oleanolic acid oleanolic,,acid oleanolic,acid pectolinarigenin-7-o-beta-d-glucopyranoside pectolinarigenin-7-o-beta-d-glucuronopyranoside pectolinarigenin-7-o-beta-d-glucuronopyranoside,methyl,ester rosmarinic,acid rosmarinic,acid,ethyl,ester schizotenuin,a scutellarin ursolic acid ursolic,,acid ursolic,acid verbascoside |
TOP | |
| 參考文獻 [1] Lee, W. S., Im, K. R., Park, Y. D., Sung, N. D., Jeong, T. S., Human ACAT-1 and ACAT-2 inhibitory activities of pentacyclic triterpenes from the leaves of Lycopus lucidus Turcz. Biological & Pharmaceutical Bulletin 2006, 29, 382-384. [2] Murata, T., Watahiki, M., Tanaka, Y., Miyase, T., Yoshizaki, F., Hyaluronidase inhibitors from Takuran, Lycopus lucidus. Chem Pharm Bull (Tokyo), 58, 394-397. [3] Woo, E. R., Piao, M. S., Antioxidative constituents from Lycopus lucidus. Arch Pharm Res 2004, 27, 173-176. [4] Edited by Jiangsu New Medical College, Chinese Medicine Dictionary, Shanghai Science and technology Press, Shanghai, 1979 (in Chinese). [5] Hao Huang, et al., CCMM, 1998, 23 (1), 37. [6] Huifang Chen, et al., Lexicon of Active Componentsin in Plants, Vol 1, Medicinal Science and Technology Press of China, Beijing, 2001 (in Chinese). [7] Lu Gan, et al., CCMM, 1998, 23 (6), 361. [8] Qiang Li, et al., CCMM, 1998, 23 (9), 570. [9] Xiaojie Tong, et al., ZYZ, 1993, 28 (3), 133. [10] Xuezhao Lu, et al., CCMM, 1997, 22 (11), 680. |
||